Diadema Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Diadema Partners's LLY Position: Q3 2026 in Review
Diadema Partners opened a new position in Eli Lilly (LLY) in Q3 2026: 60 shares worth $69.4K. The stake represents 0.01% of the portfolio and ranks #135 among its holdings. This is a return to the name: Diadema Partners previously reported a position in LLY as recently as Q1 2026.
Diadema Partners first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $15.9M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Diadema Partners held 60 shares of Eli Lilly worth $69.4K as of Q3 2026.
- Eli Lilly was a new Diadema Partners position in Q3 2026.
- Eli Lilly made up 0.01% of Diadema Partners's portfolio in Q3 2026, its #135 holding.
- Diadema Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
- Diadema Partners's Eli Lilly position peaked at $15.9M in Q1 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Diadema Partners's 13F filing for Q3 2026, filed 16 Nov 2026.